Halogenated Cyclic Diesters for Biomedical Polymers
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for a simple and versatile method to prepare polylactides and polyglycolides with improved properties, as conventional approaches are limited in modifying their physiochemical properties such as degradability and hydrophobicity.
Innovation Solution
The development of halogenated cyclic diesters and polymers, specifically fluorinated ones, which are derived from these diesters, allowing for the modification of polymer properties through the introduction of fluorine or chlorine atoms, enabling enhanced hydrolysis rates and biological compatibility.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If conventional copolymerization and block copolymer preparations are used to modify polylactides and polyglycolides, then the physiochemical properties such as degradability and hydrophobicity can be adjusted, but the preparation method becomes complex and less versatile
Solution Approach 1:
The patent applies parameter changes by introducing halogen substituents (fluoro, chloro, or halocarbon groups) at different positions (R1-R4) on the cyclic diester monomer structure. This structural parameter modification enables direct control over polymer properties such as hydrophobicity and degradability during the polymerization process itself, rather than requiring complex post-polymerization modifications through copolymerization or block copolymer preparation. The halogenated monomers can be polymerized using standard ring-opening polymerization methods, maintaining procedural simplicity while achieving property customization.
2Reliability
If halogenated cyclic diesters are synthesized and polymerized, then new properties such as enhanced hydrolysis rates and blood compatibility are achieved, but the synthesis process requires additional steps to introduce halogen atoms
Solution Approach 1:
The patent employs preliminary action by pre-introducing the halogen substituents onto the cyclic diester monomers before polymerization. This allows the halogenated functional groups to be incorporated directly into the polymer backbone during ring-opening polymerization, eliminating the need for separate post-polymerization functionalization steps. The halogenated monomers are synthesized in advance using established organic synthesis methods, and then polymerized using standard catalysts and conditions, thereby achieving complex biological properties through a streamlined two-stage process rather than multiple modification steps.
3Adaptability or versatility
If fluorinated or chlorinated substituents are introduced into the polymer structure, then hydrophobicity and degradability are improved, but the manufacturing cost increases due to specialized reagents and conditions
Solution Approach 1:
The patent applies local quality by allowing selective substitution of halogen atoms at specific positions (R1-R4) on the cyclic diester monomer structure. This enables customization of polymer properties by placing halogen groups only where needed to achieve desired hydrophobicity or degradability characteristics, rather than requiring complete fluorination or chlorination of the entire polymer structure. The localized introduction of halogen substituents reduces reagent consumption and manufacturing complexity compared to global functionalization approaches, thereby lowering costs while maintaining property versatility.
Data Source
AI summary
Halogenated cyclic diesters, halogenated polymers derived from the cyclic diesters, and methods for making the halogenated cyclic diesters and related halogenated polymers.